All Resources
Discovery, Cloning and Functional Validation of a Neoantigen-specific Patient-derived TCR

Discover a method for post-vaccination functional characterization of neoantigen-specific T cells from minimal quantity of patient peripheral blood at the single cell level using a microfluidic device on the Beacon® optofluidic system.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Poster we discuss:

The Opto® Cell Therapy Development 1.0 workflow.
Results and findings.
Surface marker stain, cytokine release and cytotoxicity assay with T cells and dendritic or T2 cells.
Cells recovered through culture process and co-culture events analyzed on the Beacon.
Get the Poster